Abilify Attorney in Pennsylvania

Fight with a Pennsylvania Defective Drugs Lawyer

In 2002, Abilify (aripiprazole) was FDA-approved to treat schizophrenia. Two years later, it was approved to treat bipolar disorder; in 2007 it was also approved to treat a major depressive disorder. It is thought that Abilify has a strong effect on important chemicals in the brain, such as dopamine, which controls pleasure. Excessive levels of dopamine can influence compulsive, addictive behaviors. Because Abilify acts as a sort of dopamine, there have been numerous reports of patients developing addictive habits as a result of taking the medication. Once the medication was stopped, the addiction stopped as well.

Has your life been negatively impacted by Abilify? Contact Handler, Henning & Rosenberg LLP today. Since 1922, our firm has stood up for the rights of the injured. Let our Pennsylvania defective drug attorney team fight on your behalf!

Side Effects of Abilify

Cases involving Abilify have shown that many individuals develop compulsive habits ranging from gambling to overeating. In many cases, these individuals experienced highly negative effects from these addictions. Throughout the years, the FDA has released several warnings as to the side effects of the drug.

FDA warnings have covered the following:

  • Diabetes & Hyperglycemia: In 2004, the FDA required that the drug manufacturers to add warnings about increased diabetes and hyperglycemia risks to the labels.
  • Suicide Warning: In 2007, the FDA required that the label be updated with a Black Box Warning indicating the increased dangers of suicide in patients under 24.
  • Death in the Elderly: In 2008, the FDA required Abilify’s labels to include a Black Box Warning regarding an increased risk of death if used to treat dementia in older patients.
  • Newborn Problems: In 2011, the FDA issued a warning informing pregnant women or women who wanted to become pregnant that exposing an infant to Abilify in the third trimester could cause abnormal muscle movement and withdrawal symptoms.
  • Impulse Control Problems: In 2016, the FDA issued a Safety Communication that warned individuals about the control problems associated with Abilify.

Call Handler, Henning & Rosenberg LLP for a Free Case Evaluation

As one of the largest firms in the area, we can devote a tremendous amount of time and resources to your case. Since the founding of our firm, our team of legal professionals has won millions on behalf of our clients and are dedicated to upholding a tradition of excellence and success. We are one of the only firms capable of handling mass torts in the area, and can efficiently represent your personal needs and concerns.

We are available 24/7 to take your calls.
Call (888) 498-3023 for a free case evaluation with one of our Pennsylvania Abilify attorneys!

  • Handler, Henning & Rosenberg LLP (717) 775-7579 1300 Linglestown Rd
    Suite 2

    Harrisburg, PA 17110
    He gave me my life and future back!
  • Handler, Henning & Rosenberg LLP (717) 775-7579 1300 Linglestown Rd
    Suite 2

    Harrisburg, PA 17110
    The whole staff was knowledgeable and the entire experience with them was great.
  • Handler, Henning & Rosenberg LLP (717) 775-7579 1300 Linglestown Rd
    Suite 2

    Harrisburg, PA 17110
    HHR was 100% on my side the whole way through.
  • Handler, Henning & Rosenberg LLP (717) 775-7579 1300 Linglestown Rd
    Suite 2

    Harrisburg, PA 17110
    I put my trust in your hands and were happy that you settled my case!
Prev Next

Client Testimonials

What Sets HHR Apart?
  • Available to our clients 24/7
  • One of the largest firms in the area
  • Millions of dollars recovered
  • Spanish speaking services available
We're Ready to Protect Your Rights
  • Please enter your name.
  • Please enter your email address.
    This isn't a valid email address.
  • This isn't a valid phone number.
    Please make a selection.
  • Please enter a message.